ZA872676B - Composition containing angiogenically active lipid containing molecules and a pharmaceutically acceptable carrier - Google Patents

Composition containing angiogenically active lipid containing molecules and a pharmaceutically acceptable carrier

Info

Publication number
ZA872676B
ZA872676B ZA872676A ZA872676A ZA872676B ZA 872676 B ZA872676 B ZA 872676B ZA 872676 A ZA872676 A ZA 872676A ZA 872676 A ZA872676 A ZA 872676A ZA 872676 B ZA872676 B ZA 872676B
Authority
ZA
South Africa
Prior art keywords
pharmaceutically acceptable
acceptable carrier
active lipid
angiogenically active
composition containing
Prior art date
Application number
ZA872676A
Other languages
English (en)
Inventor
Nicholas Catsimpoolas
Catsimpoolas Nicholas
Robert Mccluer
Mccluer Robert
James Evans
Evans James
Robert S Sinn
S Sinn Robert
Original Assignee
Angio Medical Corp
Univ Boston
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angio Medical Corp, Univ Boston filed Critical Angio Medical Corp
Publication of ZA872676B publication Critical patent/ZA872676B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA872676A 1986-04-14 1987-04-14 Composition containing angiogenically active lipid containing molecules and a pharmaceutically acceptable carrier ZA872676B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/852,444 US4769362A (en) 1985-10-01 1986-04-14 Increased vascular perfusion following administration of lipids

Publications (1)

Publication Number Publication Date
ZA872676B true ZA872676B (en) 1987-11-25

Family

ID=25313348

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA872676A ZA872676B (en) 1986-04-14 1987-04-14 Composition containing angiogenically active lipid containing molecules and a pharmaceutically acceptable carrier

Country Status (6)

Country Link
US (1) US4769362A (fr)
EP (1) EP0263174A4 (fr)
JP (1) JPH01500114A (fr)
AU (1) AU598258B2 (fr)
WO (1) WO1987006136A1 (fr)
ZA (1) ZA872676B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL125756A (en) 1996-02-15 2003-05-29 Biosense Inc Catheter for use in surgery
US6443974B1 (en) 1996-07-28 2002-09-03 Biosense, Inc. Electromagnetic cardiac biostimulation
IL119283A0 (en) * 1996-09-19 1996-12-05 Elscint Ltd Adaptive filtering
DE69838526T2 (de) 1998-02-05 2008-07-03 Biosense Webster, Inc., Diamond Bar Gerät zum Freisetzen eines Medikaments im Herzen
US20030129750A1 (en) * 1998-02-05 2003-07-10 Yitzhack Schwartz Homing of donor cells to a target zone in tissue using active therapeutics or substances
US20030113303A1 (en) * 1998-02-05 2003-06-19 Yitzhack Schwartz Homing of embryonic stem cells to a target zone in tissue using active therapeutics or substances

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0016702B1 (fr) * 1979-03-16 1985-02-20 Institut Merieux Médicament, notamment pour le traitement du choléra, et compositions pharmaceutiques le contenant
US4456596A (en) * 1981-04-13 1984-06-26 Schaefer Rolf Wound healing glycoside compositions
US4476119A (en) * 1981-08-04 1984-10-09 Fidia S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions
EP0146810A3 (fr) * 1983-12-05 1987-05-13 Solco Basel AG Procédé de préparation de dérivés de la sphingosine
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi
US4710490A (en) * 1985-10-01 1987-12-01 Angio Medical Corporation Compositions containing ganglioside molecules with enhanced angiogenic activity

Also Published As

Publication number Publication date
AU598258B2 (en) 1990-06-21
EP0263174A1 (fr) 1988-04-13
AU7283587A (en) 1987-11-09
JPH01500114A (ja) 1989-01-19
WO1987006136A1 (fr) 1987-10-22
EP0263174A4 (fr) 1988-11-24
US4769362A (en) 1988-09-06

Similar Documents

Publication Publication Date Title
GB8822857D0 (en) Pharmaceutical formulations
KR960004771B1 (en) Pharmacologically active catechol derivatives
GB8504099D0 (en) Physiologically active substances
GR871197B (en) Pharmaceutical composition with analgesic activity
NZ220441A (en) Unca-hydrazide-immunoglobulin (glyoprotein) conjugates and pharmaceutical composition
ZA894344B (en) Stable pharmaceutical composition
PT86000A (en) Pharmaceutically active compounds
GB8924052D0 (en) Pharmaceutical solution
ZA872676B (en) Composition containing angiogenically active lipid containing molecules and a pharmaceutically acceptable carrier
ZA876845B (en) Pharmacologically active compounds and use
ZA899948B (en) Pharmaceutical preparation
IL89049A0 (en) Pharmaceutical composition containing 4-aroylimidazol-2-ones
HK37795A (en) Pharmaceutically active dithioketene derivatives
GB8809803D0 (en) Pharmaceutical preparation containing felbinac
ZA874979B (en) Pharmacologically active compounds and use
ZA9015B (en) Pharmaceutical formulation
GB8902424D0 (en) Medicinal formulations
GB8805811D0 (en) Pharmaceutically active compounds
GR3020329T3 (en) Pharmaceutically active compounds
ZA878046B (en) Pharmaceutically active compounds
GB8504098D0 (en) Physiologically active substances
SG171194G (en) Pharmaceutically active dithioketene derivatives
ZA906208B (en) Paracetamol solutions and pharmaceutical formulations
IE880912L (en) Pharmaceutical composition comprising altered mammalian¹immune system cells
GB8806818D0 (en) Pharmaceutical formulation